메뉴 건너뛰기




Volumn 16, Issue 4, 2002, Pages 581-586

Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia

Author keywords

Acute leukemia; Allogeneic transplantation; Less intense conditioning

Indexed keywords

ADULT; AGED; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYCLOSPORINE; ETOPOSIDE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IDARUBICIN; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC-PHASE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

EID: 85014290809     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402423     Document Type: Review
Times cited : (18)

References (36)
  • 5
    • 0030997673 scopus 로고    scopus 로고
    • Fludarabine monophosphate reduces the incidence and severity of graft-versus-host disease in a murine model of bone marrow transplantation
    • (letter)
    • (1997) Blood , vol.90 , pp. 471
    • Or, R.1    Weiss, L.2    Teiman, S.3    Polliack, A.4
  • 14
    • 0022712686 scopus 로고
    • Censoring distributions as a measure of follow-up in survival analysis
    • (1986) Stat. Med , vol.5 , pp. 255-260
    • Korn, E.L.1
  • 27
    • 0028332425 scopus 로고
    • Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease
    • (1994) Clin. Transplant , vol.8 , pp. 258-270
    • Aschan, J.1    Ringden, O.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.